Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 DKK)

NET PROFIT (x1000 DKK)

EMPLOYEES

Share

Vifor Pharma Nordiska AB

Closing information (x1000 DKK)

Closing information 2025/06 2024/06 2023/06
Turnover 213,645 More Arrow 216,790 More Arrow 274,487
Financial expenses 602 More Arrow 611 More Arrow 891
Earnings before taxes 8,350 More Arrow 17,213 Less Arrow 4,956
EBITDA 8,446 More Arrow 17,215 Less Arrow 6,011
Total assets 220,580 More Arrow 248,208 Less Arrow 157,132
Current assets 220,579 More Arrow 248,149 Less Arrow 156,960
Current liabilities 92,382 More Arrow 128,586 Less Arrow 55,028
Equity capital 51,223 Less Arrow 44,125 Less Arrow 29,477
- share capital 134 Less Arrow 131 Less Arrow 126
Employees (average) 34 More Arrow 38 More Arrow 46

Financial ratios

Fiscal year 2025/06 2024/06 2023/06
Solvency 23.2% Less Arrow 17.8% More Arrow 18.8%
Turnover per employee 6,284 Less Arrow 5,705 More Arrow 5,967
Profit as a percentage of turnover 3.9% More Arrow 7.9% Less Arrow 1.8%
Return on assets (ROA) 4.1% More Arrow 7.2% Less Arrow 3.7%
Current ratio 238.8% Less Arrow 193.0% More Arrow 285.2%
Return on equity (ROE) 16.3% More Arrow 39.0% Less Arrow 16.8%
Change turnover -7,388 Less Arrow -68,546 More Arrow 120,461
Change turnover % -3% Less Arrow -24% More Arrow 78%
Chg. No. of employees -4 Less Arrow -8 More Arrow 6
Chg. No. of employees % -11% Less Arrow -17% More Arrow 15%

Total value of public sale

Fiscal year 2025/06 2024/06 2023/06
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.